Relaxing the substrate specificity of an aminoacyl-tRNA synthetase allows in vitro and in vivo synthesis of proteins containing unnatural amino acids.
M Ibba, H Hennecke
Index: FEBS Lett. 364(3) , 272-5, (1995)
Full Text: HTML
Abstract
It has previously been demonstrated that the unnatural amino acid p-Cl-phenylalanine can be attached to tRNA(Phe) by a modified phenylalanyl-tRNA synthetase with relaxed amino acid substrate specificity. We show that this modification to the translational machinery of Escherichia coli is the only requirement for the incorporation of either p-Cl- or p-Br-phenylalanine into full-length luciferase in vitro. The incorporation of p-Cl-phenylalanine was also demonstrated in vivo using a suitably modified host strain. These results represent the first description of the incorporation into a protein in vivo of an unnatural amino acid which is normally rejected by the cellular translational machinery.
Related Compounds
Related Articles:
Efficient introduction of aryl bromide functionality into proteins in vivo.
2000-02-04
[FEBS Lett. 467(1) , 37-40, (2000)]
Neutron capture therapy for melanoma.
1989-01-01
[Basic Life Sci. 50 , 219-32, (1989)]
Thermal neutron capture therapy: the Japanese-Australian clinical trial for malignant melanoma.
1989-01-01
[Basic Life Sci. 50 , 69-73, (1989)]
Dose fractionation in neutron capture therapy for malignant melanoma.
1989-01-01
[Basic Life Sci. 50 , 63-7, (1989)]
Structural plasticity of an aminoacyl-tRNA synthetase active site.
2006-04-25
[Proc. Natl. Acad. Sci. U. S. A. 103(17) , 6483-8, (2006)]